Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.

Wieskopf JS, Mathur J, Limapichat W, Post MR, Al-Qazzaz M, Sorge RE, Martin LJ, Zaykin DV, Smith SB, Freitas K, Austin JS, Dai F, Zhang J, Marcovitz J, Tuttle AH, Slepian PM, Clarke S, Drenan RM, Janes J, Al Sharari S, Segall SK, Aasvang EK, Lai W, Bittner R, Richards CI, Slade GD, Kehlet H, Walker J, Maskos U, Changeux JP, Devor M, Maixner W, Diatchenko L, Belfer I, Dougherty DA, Su AI, Lummis SC, Imad Damaj M, Lester HA, Patapoutian A, Mogil JS.

Sci Transl Med. 2015 May 13;7(287):287ra72. doi: 10.1126/scitranslmed.3009986.

PMID:
25972004
2.

Carbonic anhydrase-8 regulates inflammatory pain by inhibiting the ITPR1-cytosolic free calcium pathway.

Zhuang GZ, Keeler B, Grant J, Bianchi L, Fu ES, Zhang YP, Erasso DM, Cui JG, Wiltshire T, Li Q, Hao S, Sarantopoulos KD, Candiotti K, Wishnek SM, Smith SB, Maixner W, Diatchenko L, Martin ER, Levitt RC.

PLoS One. 2015 Mar 3;10(3):e0118273. doi: 10.1371/journal.pone.0118273. eCollection 2015.

3.

μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.

Convertino M, Samoshkin A, Gauthier J, Gold MS, Maixner W, Dokholyan NV, Diatchenko L.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Dec 6. pii: S0278-5846(14)00235-8. doi: 10.1016/j.pnpbp.2014.11.009. [Epub ahead of print]

PMID:
25485963
4.

The relationship among psychological and psychophysiological characteristics of fibromyalgia patients.

Thieme K, Turk DC, Gracely RH, Maixner W, Flor H.

J Pain. 2015 Feb;16(2):186-96. doi: 10.1016/j.jpain.2014.11.009. Epub 2014 Nov 26.

PMID:
25433166
5.

A pain research agenda for the 21st century.

Gereau RW 4th, Sluka KA, Maixner W, Savage SR, Price TJ, Murinson BB, Sullivan MD, Fillingim RB.

J Pain. 2014 Dec;15(12):1203-14. doi: 10.1016/j.jpain.2014.09.004. Epub 2014 Oct 29.

PMID:
25419990
6.

Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain.

Smith SB, Reenilä I, Männistö PT, Slade GD, Maixner W, Diatchenko L, Nackley AG.

Pain. 2014 Nov;155(11):2390-9. doi: 10.1016/j.pain.2014.09.009. Epub 2014 Sep 16.

PMID:
25218601
7.

Pressure pain thresholds fluctuate with, but do not usefully predict, the clinical course of painful temporomandibular disorder.

Slade GD, Sanders AE, Ohrbach R, Fillingim RB, Dubner R, Gracely RH, Bair E, Maixner W, Greenspan JD.

Pain. 2014 Oct;155(10):2134-43. doi: 10.1016/j.pain.2014.08.007. Epub 2014 Aug 15.

PMID:
25130428
8.

Chronic HPA axis response to stress in temporomandibular disorder.

Lambert CA, Sanders A, Wilder RS, Slade GD, Van Uum S, Russell E, Koren G, Maixner W.

J Dent Hyg. 2014;88 Suppl 1:5-12.

PMID:
25071145
9.

Persistent pain after endodontic therapy.

Khan AA, Maixner W, Lim PF.

J Am Dent Assoc. 2014 Mar;145(3):270-2. doi: 10.14219/jada.2013.1. No abstract available.

PMID:
24583892
10.

Natural history of comorbid orofacial pain among women with vestibulodynia.

Bair E, Simmons E, Hartung J, Desia K, Maixner W, Zolnoun D.

Clin J Pain. 2015 Jan;31(1):73-8. doi: 10.1097/AJP.0000000000000087.

PMID:
24566384
11.

From peripheral to central: the role of ERK signaling pathway in acupuncture analgesia.

Park JY, Park JJ, Jeon S, Doo AR, Kim SN, Lee H, Chae Y, Maixner W, Lee H, Park HJ.

J Pain. 2014 May;15(5):535-49. doi: 10.1016/j.jpain.2014.01.498. Epub 2014 Feb 10.

12.

Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†.

Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain.

J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151.

PMID:
24482784
13.

Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study.

Smith SB, Mir E, Bair E, Slade GD, Dubner R, Fillingim RB, Greenspan JD, Ohrbach R, Knott C, Weir B, Maixner W, Diatchenko L.

J Pain. 2013 Dec;14(12 Suppl):T91-101.e1-3. doi: 10.1016/j.jpain.2013.09.004.

14.

Psychological factors associated with development of TMD: the OPPERA prospective cohort study.

Fillingim RB, Ohrbach R, Greenspan JD, Knott C, Diatchenko L, Dubner R, Bair E, Baraian C, Mack N, Slade GD, Maixner W.

J Pain. 2013 Dec;14(12 Suppl):T75-90. doi: 10.1016/j.jpain.2013.06.009.

15.

Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study.

Greenspan JD, Slade GD, Bair E, Dubner R, Fillingim RB, Ohrbach R, Knott C, Diatchenko L, Liu Q, Maixner W.

J Pain. 2013 Dec;14(12 Suppl):T63-74.e1-6. doi: 10.1016/j.jpain.2013.06.007.

16.

General health status and incidence of first-onset temporomandibular disorder: the OPPERA prospective cohort study.

Sanders AE, Slade GD, Bair E, Fillingim RB, Knott C, Dubner R, Greenspan JD, Maixner W, Ohrbach R.

J Pain. 2013 Dec;14(12 Suppl):T51-62. doi: 10.1016/j.jpain.2013.06.001.

17.

Clinical orofacial characteristics associated with risk of first-onset TMD: the OPPERA prospective cohort study.

Ohrbach R, Bair E, Fillingim RB, Gonzalez Y, Gordon SM, Lim PF, Ribeiro-Dasilva M, Diatchenko L, Dubner R, Greenspan JD, Knott C, Maixner W, Smith SB, Slade GD.

J Pain. 2013 Dec;14(12 Suppl):T33-50. doi: 10.1016/j.jpain.2013.07.018.

18.

Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study.

Slade GD, Bair E, Greenspan JD, Dubner R, Fillingim RB, Diatchenko L, Maixner W, Knott C, Ohrbach R.

J Pain. 2013 Dec;14(12 Suppl):T20-32.e1-3. doi: 10.1016/j.jpain.2013.07.014.

19.

Study protocol, sample characteristics, and loss to follow-up: the OPPERA prospective cohort study.

Bair E, Brownstein NC, Ohrbach R, Greenspan JD, Dubner R, Fillingim RB, Maixner W, Smith SB, Diatchenko L, Gonzalez Y, Gordon SM, Lim PF, Ribeiro-Dasilva M, Dampier D, Knott C, Slade GD.

J Pain. 2013 Dec;14(12 Suppl):T2-19. doi: 10.1016/j.jpain.2013.06.006.

20.

Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: implications and future directions.

Slade GD, Fillingim RB, Sanders AE, Bair E, Greenspan JD, Ohrbach R, Dubner R, Diatchenko L, Smith SB, Knott C, Maixner W.

J Pain. 2013 Dec;14(12 Suppl):T116-24. doi: 10.1016/j.jpain.2013.09.010.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk